Cronos Group Stock Equity Positions Weight
| CRON Stock | CAD 2.71 0.01 0.37% |
Cronos Group fundamentals help investors to digest information that contributes to Cronos' financial success or failures. It also enables traders to predict the movement of Cronos Stock. The fundamental analysis module provides a way to measure Cronos' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cronos stock.
Cronos | Equity Positions Weight |
Cronos Group Company Equity Positions Weight Analysis
Cronos' Percentage of fund asset invested in equity instruments. About 80% of global funds and ETFs carry equity instruments on their balance sheet.
More About Equity Positions Weight | All Equity Analysis
Stock Percentage | = | % of Equities | in the fund |
Cronos Equity Positions Weight Driver Correlations
Understanding the fundamental principles of building solid financial models for Cronos is extremely important. It helps to project a fair market value of Cronos Stock properly, considering its historical fundamentals such as Equity Positions Weight. Since Cronos' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Cronos' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Cronos' interrelated accounts and indicators.
Click cells to compare fundamentals
Funds with most asset allocated to stocks can be subclassified into many different categories such as market capitalization or investment style.
| Competition |
According to the company disclosure, Cronos Group has an Equity Positions Weight of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Canada stocks average (which is currently at 0.0).
Cronos Current Valuation Drivers
We derive many important indicators used in calculating different scores of Cronos from analyzing Cronos' financial statements. These drivers represent accounts that assess Cronos' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Cronos' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 3.4B | 2.4B | 1.5B | 939.9M | 795.6M | 946.8M | |
| Enterprise Value | 2.2B | 1.3B | 578.5M | 179.2M | 128.8M | 122.4M |
Cronos Fundamentals
| Return On Equity | -0.0529 | ||||
| Return On Asset | -0.0373 | ||||
| Profit Margin | (0.56) % | ||||
| Operating Margin | (0.54) % | ||||
| Current Valuation | (191.19 M) | ||||
| Shares Outstanding | 382.3 M | ||||
| Shares Owned By Insiders | 46.40 % | ||||
| Shares Owned By Institutions | 15.61 % | ||||
| Number Of Shares Shorted | 4.57 M | ||||
| Price To Earning | 20.66 X | ||||
| Price To Book | 0.67 X | ||||
| Price To Sales | 10.18 X | ||||
| Revenue | 87.24 M | ||||
| Gross Profit | 11.97 M | ||||
| EBITDA | (71.8 M) | ||||
| Net Income | (74.55 M) | ||||
| Cash And Equivalents | 764.64 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 2.55 M | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 4.36 X | ||||
| Book Value Per Share | 2.88 X | ||||
| Cash Flow From Operations | (42.84 M) | ||||
| Short Ratio | 51.99 X | ||||
| Earnings Per Share | (0.17) X | ||||
| Price To Earnings To Growth | (0.54) X | ||||
| Target Price | 3.57 | ||||
| Number Of Employees | 356 | ||||
| Beta | 1.01 | ||||
| Market Capitalization | 1.04 B | ||||
| Total Asset | 1.14 B | ||||
| Retained Earnings | 416.72 M | ||||
| Working Capital | 891.91 M | ||||
| Net Asset | 1.14 B |
About Cronos Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cronos Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cronos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cronos Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
When determining whether Cronos Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cronos' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cronos Group Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cronos Group Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cronos Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.